Re: "We expect PDS will fund its operations through licensing revenue."

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jldmt

Rank: Treasurer [?]

Points: 6320 [?]

Votes: 85 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: "We expect PDS will fund its operations through licensing revenue."

in response to

"We expect PDS will fund its operations through licensing revenue."

gcduck

posted on Oct 17, 2011 05:53PM

To me this is a very positive sign regarding future licensing activity because at an other place the 10Q says the MMP is the only cash resource, hence, not to fund PDS' operations sounds like they are expecting incoming revenues SOON.